Zenflow, Inc., a South San Francisco, CA-based medical machine firm growing a minimally invasive therapy for urinary obstruction brought on by enlarged prostate, or benign prostatic hyperplasia (BPH), closed a $24m Collection C financing spherical.
The spherical contains new investor Cook dinner Medical in addition to current buyers Invus Alternatives, F-Prime Capital, Medical Know-how Enterprise Companions and others.
Led by Shreya Mehta, CEO, Zenflow is a medical machine firm devoted to bettering therapy for sufferers affected by urinary obstruction brought on by enlarged prostate. The progressive Spring® expertise depends on a small spring-like coil that lightly props open the urethra, restoring its regular operate whereas preserving the pure anatomy. The Zenflow Spring System is an investigational machine and isn’t permitted for business sale.
The corporate intends to make use of the funds for Pre-Market Approval (PMA) submission and preparation for commercialization upon FDA approval of its Spring® System.
The progress in direction of FDA approval is predicated on its stable basis of scientific analysis, protecting over 300 sufferers in a number of research together with its most up-to-date pivotal scientific trial BREEZE™, a potential, multicenter, managed examine in over 200 sufferers with decrease urinary tract signs because of enlarged prostate.
FinSMEs
18/11/2024
